Valiant Co

Valiant Co Accounts Payable

The Accounts Payable of Valiant Co (002643.SZ) as of Nov 19, 2026 is 578.38 M CNY. In the previous year, Accounts Payable was 476.73 M CNY — a change of 21.32% (higher).

Accounts Payable

578.38 MCNY

YoY

21.32%

Last updated:

Accounts Payable of Valiant Co is 2025 578.38 M CNY. Accounts Payable of Valiant Co was 2024 476.73 M CNY. It decreases by 21.32% higher compared to the previous year.

The Valiant Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
261.95 M CNY
Jan 1, 2019
391.80 M CNY
Jan 1, 2020
383.49 M CNY
Jan 1, 2021
669.84 M CNY
Jan 1, 2022
937.10 M CNY
Jan 1, 2023
595.31 M CNY
Jan 1, 2024
476.73 M CNY
Jan 1, 2025
578.38 M CNY
The Valiant Co Accounts Payable history
YEARAccounts PayableYoY
578.38 MCNY+21.32%
476.73 MCNY-19.92%
595.31 MCNY-36.47%
937.10 MCNY+39.90%
669.84 MCNY+74.67%
383.49 MCNY-2.12%
391.80 MCNY+49.57%
261.95 MCNY+1.04%
259.24 MCNY-0.23%
259.84 MCNY-18.52%
318.92 MCNY+114.79%
148.48 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Accounts Payable of Valiant Co is 578.38 M CNY in 2025.

Accounts Payable of Valiant Co changed from 476.73 M CNY to 578.38 M CNY, representing a 21.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Valiant Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valiant Co

All Key Metrics — Valiant Co